Divis Laboratories has reported results for third quarter ended December 31, 2013.
The company has reported 51.84% rise in its net profit at Rs 219.02 crore for the quarter, as compared to Rs 144.24 crore for the same quarter in the previous year. Total income of the company increased by 25.24% at Rs 697.18 crore for quarter under review as compared to Rs 556.68 crore for the quarter ended December 31, 2012.
Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.
The company has reported 51.84% rise in its net profit at Rs 219.02 crore for the quarter, as compared to Rs 144.24 crore for the same quarter in the previous year. Total income of the company increased by 25.24% at Rs 697.18 crore for quarter under review as compared to Rs 556.68 crore for the quarter ended December 31, 2012.
Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.
No comments:
Post a Comment